Apóstolo João, Cooke Richard, Bobrowicz-Campos Elzbieta, Santana Silvina, Marcucci Maura, Cano Antonio, Vollenbroek-Hutten Miriam, Germini Federico, D'Avanzo Barbara, Gwyther Holly, Holland Carol
Health Sciences Research Unit: Nursing, Nursing School of Coimbra, Portugal Centre for Evidence Based Practice: a Joanna Briggs Institute Centre of Excellence.
Aston Research Centre for Healthy Ageing (ARCHA), Aston University, Birmingham, United Kingdom.
JBI Database System Rev Implement Rep. 2018 Jan;16(1):140-232. doi: 10.11124/JBISRIR-2017-003382.
To summarize the best available evidence regarding the effectiveness of interventions for preventing frailty progression in older adults.
Frailty is an age-related state of decreased physiological reserves characterized by an increased risk of poor clinical outcomes. Evidence supporting the malleability of frailty, its prevention and treatment, has been presented.
The review considered studies on older adults aged 65 and over, explicitly identified as pre-frail or frail, who had been undergoing interventions focusing on the prevention of frailty progression. Participants selected on the basis of specific illness or with a terminal diagnosis were excluded. The comparator was usual care, alternative therapeutic interventions or no intervention. The primary outcome was frailty. Secondary outcomes included: (i) cognition, quality of life, activities of daily living, caregiver burden, functional capacity, depression and other mental health-related outcomes, self-perceived health and social engagement; (ii) drugs and prescriptions, analytical parameters, adverse outcomes and comorbidities; (iii) costs, and/or costs relative to benefits and/or savings associated with implementing the interventions for frailty. Experimental study designs, cost effectiveness, cost benefit, cost minimization and cost utility studies were considered for inclusion.
Databases for published and unpublished studies, available in English, Portuguese, Spanish, Italian and Dutch, from January 2001 to November 2015, were searched. Critical appraisal was conducted using standardized instruments from the Joanna Briggs Institute. Data was extracted using the standardized tools designed for quantitative and economic studies. Data was presented in a narrative form due to the heterogeneity of included studies.
Twenty-one studies, all randomized controlled trials, with a total of 5275 older adults and describing 33 interventions, met the criteria for inclusion. Economic analyses were conducted in two studies. Physical exercise programs were shown to be generally effective for reducing or postponing frailty but only when conducted in groups. Favorable effects on frailty indicators were also observed after the interventions, based on physical exercise with supplementation, supplementation alone, cognitive training and combined treatment. Group meetings and home visits were not found to be universally effective. Lack of efficacy was evidenced for physical exercise performed individually or delivered one-to-one, hormone supplementation and problem solving therapy. Individually tailored management programs for clinical conditions had inconsistent effects on frailty prevalence. Economic studies demonstrated that this type of intervention, as compared to usual care, provided better value for money, particularly for very frail community-dwelling participants, and had favorable effects in some of the frailty-related outcomes in inpatient and outpatient management, without increasing costs.
This review found mixed results regarding the effectiveness of frailty interventions. However, there is clear evidence on the usefulness of such interventions in carefully chosen evidence-based circumstances, both for frailty itself and for secondary outcomes, supporting clinical investment of resources in frailty intervention. Further research is required to reinforce current evidence and examine the impact of the initial level of frailty on the benefits of different interventions. There is also a need for economic evaluation of frailty interventions.
总结关于预防老年人衰弱进展干预措施有效性的最佳现有证据。
衰弱是一种与年龄相关的生理储备下降状态,其特征是临床不良结局风险增加。已有证据支持衰弱的可塑性及其预防和治疗。
本综述纳入了针对65岁及以上老年人的研究,这些老年人被明确认定为衰弱前期或衰弱状态,且正在接受旨在预防衰弱进展的干预措施。基于特定疾病或终末期诊断选择的参与者被排除。对照为常规护理、替代治疗干预措施或不进行干预。主要结局为衰弱。次要结局包括:(i)认知、生活质量、日常生活活动、照料者负担、功能能力、抑郁及其他与心理健康相关的结局、自我感知健康和社会参与;(ii)药物和处方、分析参数、不良结局和合并症;(iii)成本,和/或相对于实施衰弱干预措施的效益和/或节省的成本。纳入的研究类型包括实验性研究设计、成本效益、成本效益分析、成本最小化和成本效用研究。
检索了2001年1月至2015年11月期间以英文、葡萄牙文、西班牙文、意大利文和荷兰文发表及未发表研究的数据库。使用乔安娜·布里格斯研究所的标准化工具进行批判性评价。使用为定量和经济研究设计的标准化工具提取数据。由于纳入研究的异质性,数据以叙述形式呈现。
21项研究均为随机对照试验,共纳入5275名老年人,描述了33种干预措施,符合纳入标准。两项研究进行了经济分析。体育锻炼计划通常显示对减少或推迟衰弱有效,但仅在集体进行时有效。基于体育锻炼加补充剂、单独补充剂、认知训练和联合治疗的干预措施后,对衰弱指标也观察到了有利影响。小组会议和家访并非普遍有效。单独进行或一对一实施的体育锻炼、激素补充和解决问题疗法缺乏疗效。针对临床状况的个体化管理计划对衰弱患病率的影响不一致。经济研究表明,与常规护理相比,这类干预措施性价比更高,尤其是对于非常衰弱的社区居住参与者,并且在住院和门诊管理中对一些与衰弱相关的结局有有利影响,且不增加成本。
本综述发现衰弱干预措施有效性的结果不一。然而,有明确证据表明,在精心选择的基于证据的情况下,此类干预措施对于衰弱本身和次要结局均有用,支持在衰弱干预方面进行临床资源投入。需要进一步研究以加强现有证据,并检验衰弱初始水平对不同干预措施效益的影响。还需要对衰弱干预措施进行经济评估。